Frost Radar™: Global Endoscopy Market, 2020
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
22-Dec-2020
Global
Frost Radar
$4,950.00
Special Price $3,712.50 save 25 %
Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of “elective surgeries” that were postponed due to the COVID-19 pandemic. Specifically, the amount of surgeries involving the gastrointestinal (GI) tract, urology, and gynecology will flood healthcare systems once the world recovers from the pandemic, thus leading to increased use of endoscopy devices. Because minimally invasive surgeries substantially reduce a patient’s time in hospital and minimize post-operative complications, this approach is preferred by both patients and doctors.
The US Food and Drug Administration (FDA) issued safety recommendations to use partially or fully-disposable duodenoscopes; that, in addition to the awareness COVID-19 created about infection prevention have boosted the development of single-use duodenoscopes and endoscopes. The FDA’s recommendation is based on the fact that certain endoscope devices come with complicated designs and hard-to-clean components, which pose contamination risk from one patient to another if not correctly reprocessed and sterilized.
To supply innovative endoscopic technologies, leading market players aim to differentiate themselves with disruptive breakthroughs and distinctive market expansion strategies. Novel endoscope types are gaining increased attention, such as capsule administered, artificial intelligence (AI)-powered, and robotic-assisted. These advancements effectively propel the global endoscopy devices market by setting new standards of care delivery and enhanced patient health outcomes.
Frost & Sullivan’s research indicates that the global endoscopy market, which is currently crowded by traditional rigid and reprocessed endoscopes, will soon experience a major shift toward flexible single-use devices. The technological innovations are expected to introduce major transformation to the market and create new standards of safety, efficiency, cost-effectiveness, and enhanced quality of care.
In a field of more than 70 global industry participants, Frost & Sullivan independently plotted the top 13 companies in this Frost Radar™ analysis. The Frost Radar™ reveals the market positioning of each company using its Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies based on their strengths, opportunities, and market positioning. We discuss strategic market imperatives and the competitive environment that vendors operate in as well as make recommendations for each provider to spur growth.
Author: Suchismita Das

Strategic Imperative
Strategic Imperative (continued)
Growth Environment
Growth Environment (continued)
Frost Radar™: Global Endoscopy Market
Frost Radar™: Competitive Environment
Frost Radar™: Competitive Environment (continued)
Olympus Corporation
Boston Scientific
Karl Storz-Endoskope
Medtronic plc.
Ambu A/S
Fujifilm Healthcare
Smith & Nephew, Inc.
Stryker Corporation
B. Braun
ConMed Corporation
PENTAX Medical
Auris Health
CapsoVision, Inc.
Strategic Insights
Significance of Being on the Frost Radar™
Frost Radar™ Empowers the CEO’s Growth Team
Frost Radar™ Empowers Investors
Frost Radar™ Empowers Customers
Frost Radar™ Empowers the Board of Directors
Frost Radar™: Benchmarking Future Growth Potential
Frost Radar™: Benchmarking Future Growth Potential
Legal Disclaimer
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
-
Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. -
Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. -
Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. -
Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? -
Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
-
INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. -
RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. -
PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. -
MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. -
CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
-
GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. -
BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. -
COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. -
CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. -
PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Deliverable Type | Frost Radar |
---|---|
No Index | No |
Podcast | No |
Author | Suchismita Das |
Industries | Healthcare |
WIP Number | MFDE-01-00-00-00 |
Is Prebook | No |
GPS Codes | 9600-B1,9A4B-B1 |